2-170966080-G-A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015530.5(GORASP2):c.1309G>A(p.Glu437Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,614,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E437A) has been classified as Uncertain significance.
Frequency
Consequence
NM_015530.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251340 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461828Hom.: 1 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727214 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74466 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1309G>A (p.E437K) alteration is located in exon 10 (coding exon 10) of the GORASP2 gene. This alteration results from a G to A substitution at nucleotide position 1309, causing the glutamic acid (E) at amino acid position 437 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at